[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Betamethasone Market - Global Outlook and Forecast 2021-2027

April 2021 | 109 pages | ID: B97AA5EBA844EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Betamethasone in Global, including the following market information:

Global Betamethasone Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Betamethasone market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Betamethasone companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Betamethasone Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Betamethasone Market Segment Percentages, By Type, 2020 (%)
  • Injection
  • Active Pharmaceutical Ingredients
  • Tablets
  • Ointment
  • Cream
  • Gel
  • Lotion
  • Other
China Betamethasone Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Betamethasone Market Segment Percentages, By Application, 2020 (%)
  • Systemic Traumatic Pain
  • Meniere's Disease
  • Hearing Loss
  • Dry Eye Syndrome
  • Eczema
  • Rheumatism
  • Acute Leukemia
  • Severe Bronchial Asthma
  • Comprehensive Treatment Of Infection
  • Other
Global Betamethasone Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Betamethasone Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Betamethasone Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Betamethasone Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • GlaxoSmithKline
  • East West Pharma
  • Omega Remedies
  • Moraceae Pharmaceuticals
  • Emson Medichem
  • Watson Pharma(Allergan)
  • Taro Pharmaceuticals
  • Icn Pharmaceuticals
  • UCB, Inc
  • Fougera
  • Impax (Amneal Pharmaceuticals)
  • VersaPharm (Akorn)
  • Nucare Pharmaceuticals
  • PD-Rx Pharmaceuticals
  • LEO Pharma
  • Orbis Biosciences
  • Surface Pharmaceuticals
  • Maruho
  • Dr. Reddy’s
  • Iroko Pharma
  • Tianjin Tianyao Pharmaceutical
  • Tianjin Jinyao Group
  • Suicheng Pharmaceutical
  • Shanghai Pharmaceutical
  • Shandong Shenglu Pharmaceutical
  • Maanshan Fengyuan Pharmaceutical
  • Henan Lihua Pharmaceutical
  • SINOPHARM
  • Chengdu Mount Tiantai Pharmaceutical
  • Chenxin Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Betamethasone Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Betamethasone Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BETAMETHASONE OVERALL MARKET SIZE

2.1 Global Betamethasone Market Size: 2021 VS 2027
2.2 Global Betamethasone Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Betamethasone Players in Global Market
3.2 Top Global Betamethasone Companies Ranked by Revenue
3.3 Global Betamethasone Revenue by Companies
3.4 Top 3 and Top 5 Betamethasone Companies in Global Market, by Revenue in 2020
3.5 Global Companies Betamethasone Product Type
3.6 Tier 1, Tier 2 and Tier 3 Betamethasone Players in Global Market
  3.6.1 List of Global Tier 1 Betamethasone Companies
  3.6.2 List of Global Tier 2 and Tier 3 Betamethasone Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Betamethasone Market Size Markets, 2021 & 2027
  4.1.2 Injection
  4.1.3 Active Pharmaceutical Ingredients
  4.1.4 Tablets
  4.1.5 Ointment
  4.1.6 Cream
  4.1.7 Gel
  4.1.8 Lotion
  4.1.9 Other
4.2 By Type - Global Betamethasone Revenue & Forecasts
  4.2.1 By Type - Global Betamethasone Revenue, 2016-2021
  4.2.2 By Type - Global Betamethasone Revenue, 2022-2027
  4.2.3 By Type - Global Betamethasone Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Betamethasone Market Size, 2021 & 2027
  5.1.2 Systemic Traumatic Pain
  5.1.3 Meniere's Disease
  5.1.4 Hearing Loss
  5.1.5 Dry Eye Syndrome
  5.1.6 Eczema
  5.1.7 Rheumatism
  5.1.8 Acute Leukemia
  5.1.9 Severe Bronchial Asthma
  5.1.10 Comprehensive Treatment Of Infection
  5.1.11 Other
5.2 By Application - Global Betamethasone Revenue & Forecasts
  5.2.1 By Application - Global Betamethasone Revenue, 2016-2021
  5.2.2 By Application - Global Betamethasone Revenue, 2022-2027
  5.2.3 By Application - Global Betamethasone Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Betamethasone Market Size, 2021 & 2027
6.2 By Region - Global Betamethasone Revenue & Forecasts
  6.2.1 By Region - Global Betamethasone Revenue, 2016-2021
  6.2.2 By Region - Global Betamethasone Revenue, 2022-2027
  6.2.3 By Region - Global Betamethasone Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Betamethasone Revenue, 2016-2027
  6.3.2 US Betamethasone Market Size, 2016-2027
  6.3.3 Canada Betamethasone Market Size, 2016-2027
  6.3.4 Mexico Betamethasone Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Betamethasone Revenue, 2016-2027
  6.4.2 Germany Betamethasone Market Size, 2016-2027
  6.4.3 France Betamethasone Market Size, 2016-2027
  6.4.4 U.K. Betamethasone Market Size, 2016-2027
  6.4.5 Italy Betamethasone Market Size, 2016-2027
  6.4.6 Russia Betamethasone Market Size, 2016-2027
  6.4.7 Nordic Countries Betamethasone Market Size, 2016-2027
  6.4.8 Benelux Betamethasone Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Betamethasone Revenue, 2016-2027
  6.5.2 China Betamethasone Market Size, 2016-2027
  6.5.3 Japan Betamethasone Market Size, 2016-2027
  6.5.4 South Korea Betamethasone Market Size, 2016-2027
  6.5.5 Southeast Asia Betamethasone Market Size, 2016-2027
  6.5.6 India Betamethasone Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Betamethasone Revenue, 2016-2027
  6.6.2 Brazil Betamethasone Market Size, 2016-2027
  6.6.3 Argentina Betamethasone Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Betamethasone Revenue, 2016-2027
  6.7.2 Turkey Betamethasone Market Size, 2016-2027
  6.7.3 Israel Betamethasone Market Size, 2016-2027
  6.7.4 Saudi Arabia Betamethasone Market Size, 2016-2027
  6.7.5 UAE Betamethasone Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Corporate Summary
  7.1.2 GlaxoSmithKline Business Overview
  7.1.3 GlaxoSmithKline Betamethasone Major Product Offerings
  7.1.4 GlaxoSmithKline Betamethasone Revenue in Global (2016-2021)
  7.1.5 GlaxoSmithKline Key News
7.2 East West Pharma
  7.2.1 East West Pharma Corporate Summary
  7.2.2 East West Pharma Business Overview
  7.2.3 East West Pharma Betamethasone Major Product Offerings
  7.2.4 East West Pharma Betamethasone Revenue in Global (2016-2021)
  7.2.5 East West Pharma Key News
7.3 Omega Remedies
  7.3.1 Omega Remedies Corporate Summary
  7.3.2 Omega Remedies Business Overview
  7.3.3 Omega Remedies Betamethasone Major Product Offerings
  7.3.4 Omega Remedies Betamethasone Revenue in Global (2016-2021)
  7.3.5 Omega Remedies Key News
7.4 Moraceae Pharmaceuticals
  7.4.1 Moraceae Pharmaceuticals Corporate Summary
  7.4.2 Moraceae Pharmaceuticals Business Overview
  7.4.3 Moraceae Pharmaceuticals Betamethasone Major Product Offerings
  7.4.4 Moraceae Pharmaceuticals Betamethasone Revenue in Global (2016-2021)
  7.4.5 Moraceae Pharmaceuticals Key News
7.5 Emson Medichem
  7.5.1 Emson Medichem Corporate Summary
  7.5.2 Emson Medichem Business Overview
  7.5.3 Emson Medichem Betamethasone Major Product Offerings
  7.5.4 Emson Medichem Betamethasone Revenue in Global (2016-2021)
  7.5.5 Emson Medichem Key News
7.6 Watson Pharma(Allergan)
  7.6.1 Watson Pharma(Allergan) Corporate Summary
  7.6.2 Watson Pharma(Allergan) Business Overview
  7.6.3 Watson Pharma(Allergan) Betamethasone Major Product Offerings
  7.6.4 Watson Pharma(Allergan) Betamethasone Revenue in Global (2016-2021)
  7.6.5 Watson Pharma(Allergan) Key News
7.7 Taro Pharmaceuticals
  7.7.1 Taro Pharmaceuticals Corporate Summary
  7.7.2 Taro Pharmaceuticals Business Overview
  7.7.3 Taro Pharmaceuticals Betamethasone Major Product Offerings
  7.4.4 Taro Pharmaceuticals Betamethasone Revenue in Global (2016-2021)
  7.7.5 Taro Pharmaceuticals Key News
7.8 Icn Pharmaceuticals
  7.8.1 Icn Pharmaceuticals Corporate Summary
  7.8.2 Icn Pharmaceuticals Business Overview
  7.8.3 Icn Pharmaceuticals Betamethasone Major Product Offerings
  7.8.4 Icn Pharmaceuticals Betamethasone Revenue in Global (2016-2021)
  7.8.5 Icn Pharmaceuticals Key News
7.9 UCB, Inc
  7.9.1 UCB, Inc Corporate Summary
  7.9.2 UCB, Inc Business Overview
  7.9.3 UCB, Inc Betamethasone Major Product Offerings
  7.9.4 UCB, Inc Betamethasone Revenue in Global (2016-2021)
  7.9.5 UCB, Inc Key News
7.10 Fougera
  7.10.1 Fougera Corporate Summary
  7.10.2 Fougera Business Overview
  7.10.3 Fougera Betamethasone Major Product Offerings
  7.10.4 Fougera Betamethasone Revenue in Global (2016-2021)
  7.10.5 Fougera Key News
7.11 Impax (Amneal Pharmaceuticals)
  7.11.1 Impax (Amneal Pharmaceuticals) Corporate Summary
  7.11.2 Impax (Amneal Pharmaceuticals) Business Overview
  7.11.3 Impax (Amneal Pharmaceuticals) Betamethasone Major Product Offerings
  7.11.4 Impax (Amneal Pharmaceuticals) Betamethasone Revenue in Global (2016-2021)
  7.11.5 Impax (Amneal Pharmaceuticals) Key News
7.12 VersaPharm (Akorn)
  7.12.1 VersaPharm (Akorn) Corporate Summary
  7.12.2 VersaPharm (Akorn) Business Overview
  7.12.3 VersaPharm (Akorn) Betamethasone Major Product Offerings
  7.12.4 VersaPharm (Akorn) Betamethasone Revenue in Global (2016-2021)
  7.12.5 VersaPharm (Akorn) Key News
7.13 Nucare Pharmaceuticals
  7.13.1 Nucare Pharmaceuticals Corporate Summary
  7.13.2 Nucare Pharmaceuticals Business Overview
  7.13.3 Nucare Pharmaceuticals Betamethasone Major Product Offerings
  7.13.4 Nucare Pharmaceuticals Betamethasone Revenue in Global (2016-2021)
  7.13.5 Nucare Pharmaceuticals Key News
7.14 PD-Rx Pharmaceuticals
  7.14.1 PD-Rx Pharmaceuticals Corporate Summary
  7.14.2 PD-Rx Pharmaceuticals Business Overview
  7.14.3 PD-Rx Pharmaceuticals Betamethasone Major Product Offerings
  7.14.4 PD-Rx Pharmaceuticals Betamethasone Revenue in Global (2016-2021)
  7.14.5 PD-Rx Pharmaceuticals Key News
7.15 LEO Pharma
  7.15.1 LEO Pharma Corporate Summary
  7.15.2 LEO Pharma Business Overview
  7.15.3 LEO Pharma Betamethasone Major Product Offerings
  7.15.4 LEO Pharma Betamethasone Revenue in Global (2016-2021)
  7.15.5 LEO Pharma Key News
7.16 Orbis Biosciences
  7.16.1 Orbis Biosciences Corporate Summary
  7.16.2 Orbis Biosciences Business Overview
  7.16.3 Orbis Biosciences Betamethasone Major Product Offerings
  7.16.4 Orbis Biosciences Betamethasone Revenue in Global (2016-2021)
  7.16.5 Orbis Biosciences Key News
7.17 Surface Pharmaceuticals
  7.17.1 Surface Pharmaceuticals Corporate Summary
  7.17.2 Surface Pharmaceuticals Business Overview
  7.17.3 Surface Pharmaceuticals Betamethasone Major Product Offerings
  7.17.4 Surface Pharmaceuticals Betamethasone Revenue in Global (2016-2021)
  7.17.5 Surface Pharmaceuticals Key News
7.18 Maruho
  7.18.1 Maruho Corporate Summary
  7.18.2 Maruho Business Overview
  7.18.3 Maruho Betamethasone Major Product Offerings
  7.18.4 Maruho Betamethasone Revenue in Global (2016-2021)
  7.18.5 Maruho Key News
7.19 Dr. Reddy’s
  7.19.1 Dr. Reddy’s Corporate Summary
  7.19.2 Dr. Reddy’s Business Overview
  7.19.3 Dr. Reddy’s Betamethasone Major Product Offerings
  7.19.4 Dr. Reddy’s Betamethasone Revenue in Global (2016-2021)
  7.19.5 Dr. Reddy’s Key News
7.20 Iroko Pharma
  7.20.1 Iroko Pharma Corporate Summary
  7.20.2 Iroko Pharma Business Overview
  7.20.3 Iroko Pharma Betamethasone Major Product Offerings
  7.20.4 Iroko Pharma Betamethasone Revenue in Global (2016-2021)
  7.20.5 Iroko Pharma Key News
7.21 Tianjin Tianyao Pharmaceutical
  7.21.1 Tianjin Tianyao Pharmaceutical Corporate Summary
  7.21.2 Tianjin Tianyao Pharmaceutical Business Overview
  7.21.3 Tianjin Tianyao Pharmaceutical Betamethasone Major Product Offerings
  7.21.4 Tianjin Tianyao Pharmaceutical Betamethasone Revenue in Global (2016-2021)
  7.21.5 Tianjin Tianyao Pharmaceutical Key News
7.22 Tianjin Jinyao Group
  7.22.1 Tianjin Jinyao Group Corporate Summary
  7.22.2 Tianjin Jinyao Group Business Overview
  7.22.3 Tianjin Jinyao Group Betamethasone Major Product Offerings
  7.22.4 Tianjin Jinyao Group Betamethasone Revenue in Global (2016-2021)
  7.22.5 Tianjin Jinyao Group Key News
7.23 Suicheng Pharmaceutical
  7.23.1 Suicheng Pharmaceutical Corporate Summary
  7.23.2 Suicheng Pharmaceutical Business Overview
  7.23.3 Suicheng Pharmaceutical Betamethasone Major Product Offerings
  7.23.4 Suicheng Pharmaceutical Betamethasone Revenue in Global (2016-2021)
  7.23.5 Suicheng Pharmaceutical Key News
7.24 Shanghai Pharmaceutical
  7.24.1 Shanghai Pharmaceutical Corporate Summary
  7.24.2 Shanghai Pharmaceutical Business Overview
  7.24.3 Shanghai Pharmaceutical Betamethasone Major Product Offerings
  7.24.4 Shanghai Pharmaceutical Betamethasone Revenue in Global (2016-2021)
  7.24.5 Shanghai Pharmaceutical Key News
7.25 Shandong Shenglu Pharmaceutical
  7.25.1 Shandong Shenglu Pharmaceutical Corporate Summary
  7.25.2 Shandong Shenglu Pharmaceutical Business Overview
  7.25.3 Shandong Shenglu Pharmaceutical Betamethasone Major Product Offerings
  7.25.4 Shandong Shenglu Pharmaceutical Betamethasone Revenue in Global (2016-2021)
  7.25.5 Shandong Shenglu Pharmaceutical Key News
7.26 Maanshan Fengyuan Pharmaceutical
  7.26.1 Maanshan Fengyuan Pharmaceutical Corporate Summary
  7.26.2 Maanshan Fengyuan Pharmaceutical Business Overview
  7.26.3 Maanshan Fengyuan Pharmaceutical Betamethasone Major Product Offerings
  7.26.4 Maanshan Fengyuan Pharmaceutical Betamethasone Revenue in Global (2016-2021)
  7.26.5 Maanshan Fengyuan Pharmaceutical Key News
7.27 Henan Lihua Pharmaceutical
  7.27.1 Henan Lihua Pharmaceutical Corporate Summary
  7.27.2 Henan Lihua Pharmaceutical Business Overview
  7.27.3 Henan Lihua Pharmaceutical Betamethasone Major Product Offerings
  7.27.4 Henan Lihua Pharmaceutical Betamethasone Revenue in Global (2016-2021)
  7.27.5 Henan Lihua Pharmaceutical Key News
7.28 SINOPHARM
  7.28.1 SINOPHARM Corporate Summary
  7.28.2 SINOPHARM Business Overview
  7.28.3 SINOPHARM Betamethasone Major Product Offerings
  7.28.4 SINOPHARM Betamethasone Revenue in Global (2016-2021)
  7.28.5 SINOPHARM Key News
7.29 Chengdu Mount Tiantai Pharmaceutical
  7.29.1 Chengdu Mount Tiantai Pharmaceutical Corporate Summary
  7.29.2 Chengdu Mount Tiantai Pharmaceutical Business Overview
  7.29.3 Chengdu Mount Tiantai Pharmaceutical Betamethasone Major Product Offerings
  7.29.4 Chengdu Mount Tiantai Pharmaceutical Betamethasone Revenue in Global (2016-2021)
  7.29.5 Chengdu Mount Tiantai Pharmaceutical Key News
7.30 Chenxin Pharmaceutical
  7.30.1 Chenxin Pharmaceutical Corporate Summary
  7.30.2 Chenxin Pharmaceutical Business Overview
  7.30.3 Chenxin Pharmaceutical Betamethasone Major Product Offerings
  7.30.4 Chenxin Pharmaceutical Betamethasone Revenue in Global (2016-2021)
  7.30.5 Chenxin Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Betamethasone Market Opportunities & Trends in Global Market
Table 2. Betamethasone Market Drivers in Global Market
Table 3. Betamethasone Market Restraints in Global Market
Table 4. Key Players of Betamethasone in Global Market
Table 5. Top Betamethasone Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Betamethasone Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Betamethasone Revenue Share by Companies, 2016-2021
Table 8. Global Companies Betamethasone Product Type
Table 9. List of Global Tier 1 Betamethasone Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Betamethasone Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Betamethasone Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Betamethasone Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Betamethasone Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Betamethasone Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Betamethasone Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Betamethasone Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Betamethasone Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Betamethasone Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Betamethasone Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Betamethasone Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Betamethasone Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Betamethasone Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Betamethasone Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Betamethasone Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Betamethasone Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Betamethasone Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Betamethasone Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Betamethasone Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Betamethasone Revenue, (US$, Mn), 2022-2027
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Betamethasone Product Offerings
Table 32. GlaxoSmithKline Betamethasone Revenue (US$, Mn), (2016-2021)
Table 33. East West Pharma Corporate Summary
Table 34. East West Pharma Betamethasone Product Offerings
Table 35. East West Pharma Betamethasone Revenue (US$, Mn), (2016-2021)
Table 36. Omega Remedies Corporate Summary
Table 37. Omega Remedies Betamethasone Product Offerings
Table 38. Omega Remedies Betamethasone Revenue (US$, Mn), (2016-2021)
Table 39. Moraceae Pharmaceuticals Corporate Summary
Table 40. Moraceae Pharmaceuticals Betamethasone Product Offerings
Table 41. Moraceae Pharmaceuticals Betamethasone Revenue (US$, Mn), (2016-2021)
Table 42. Emson Medichem Corporate Summary
Table 43. Emson Medichem Betamethasone Product Offerings
Table 44. Emson Medichem Betamethasone Revenue (US$, Mn), (2016-2021)
Table 45. Watson Pharma(Allergan) Corporate Summary
Table 46. Watson Pharma(Allergan) Betamethasone Product Offerings
Table 47. Watson Pharma(Allergan) Betamethasone Revenue (US$, Mn), (2016-2021)
Table 48. Taro Pharmaceuticals Corporate Summary
Table 49. Taro Pharmaceuticals Betamethasone Product Offerings
Table 50. Taro Pharmaceuticals Betamethasone Revenue (US$, Mn), (2016-2021)
Table 51. Icn Pharmaceuticals Corporate Summary
Table 52. Icn Pharmaceuticals Betamethasone Product Offerings
Table 53. Icn Pharmaceuticals Betamethasone Revenue (US$, Mn), (2016-2021)
Table 54. UCB, Inc Corporate Summary
Table 55. UCB, Inc Betamethasone Product Offerings
Table 56. UCB, Inc Betamethasone Revenue (US$, Mn), (2016-2021)
Table 57. Fougera Corporate Summary
Table 58. Fougera Betamethasone Product Offerings
Table 59. Fougera Betamethasone Revenue (US$, Mn), (2016-2021)
Table 60. Impax (Amneal Pharmaceuticals) Corporate Summary
Table 61. Impax (Amneal Pharmaceuticals) Betamethasone Product Offerings
Table 62. Impax (Amneal Pharmaceuticals) Betamethasone Revenue (US$, Mn), (2016-2021)
Table 63. VersaPharm (Akorn) Corporate Summary
Table 64. VersaPharm (Akorn) Betamethasone Product Offerings
Table 65. VersaPharm (Akorn) Betamethasone Revenue (US$, Mn), (2016-2021)
Table 66. Nucare Pharmaceuticals Corporate Summary
Table 67. Nucare Pharmaceuticals Betamethasone Product Offerings
Table 68. Nucare Pharmaceuticals Betamethasone Revenue (US$, Mn), (2016-2021)
Table 69. PD-Rx Pharmaceuticals Corporate Summary
Table 70. PD-Rx Pharmaceuticals Betamethasone Product Offerings
Table 71. PD-Rx Pharmaceuticals Betamethasone Revenue (US$, Mn), (2016-2021)
Table 72. LEO Pharma Corporate Summary
Table 73. LEO Pharma Betamethasone Product Offerings
Table 74. LEO Pharma Betamethasone Revenue (US$, Mn), (2016-2021)
Table 75. Orbis Biosciences Corporate Summary
Table 76. Orbis Biosciences Betamethasone Product Offerings
Table 77. Orbis Biosciences Betamethasone Revenue (US$, Mn), (2016-2021)
Table 78. Surface Pharmaceuticals Corporate Summary
Table 79. Surface Pharmaceuticals Betamethasone Product Offerings
Table 80. Surface Pharmaceuticals Betamethasone Revenue (US$, Mn), (2016-2021)
Table 81. Maruho Corporate Summary
Table 82. Maruho Betamethasone Product Offerings
Table 83. Maruho Betamethasone Revenue (US$, Mn), (2016-2021)
Table 84. Dr. Reddy’s Corporate Summary
Table 85. Dr. Reddy’s Betamethasone Product Offerings
Table 86. Dr. Reddy’s Betamethasone Revenue (US$, Mn), (2016-2021)
Table 87. Iroko Pharma Corporate Summary
Table 88. Iroko Pharma Betamethasone Product Offerings
Table 89. Iroko Pharma Betamethasone Revenue (US$, Mn), (2016-2021)
Table 90. Tianjin Tianyao Pharmaceutical Corporate Summary
Table 91. Tianjin Tianyao Pharmaceutical Betamethasone Product Offerings
Table 92. Tianjin Tianyao Pharmaceutical Betamethasone Revenue (US$, Mn), (2016-2021)
Table 93. Tianjin Jinyao Group Corporate Summary
Table 94. Tianjin Jinyao Group Betamethasone Product Offerings
Table 95. Tianjin Jinyao Group Betamethasone Revenue (US$, Mn), (2016-2021)
Table 96. Suicheng Pharmaceutical Corporate Summary
Table 97. Suicheng Pharmaceutical Betamethasone Product Offerings
Table 98. Suicheng Pharmaceutical Betamethasone Revenue (US$, Mn), (2016-2021)
Table 99. Shanghai Pharmaceutical Corporate Summary
Table 100. Shanghai Pharmaceutical Betamethasone Product Offerings
Table 101. Shanghai Pharmaceutical Betamethasone Revenue (US$, Mn), (2016-2021)
Table 102. Shandong Shenglu Pharmaceutical Corporate Summary
Table 103. Shandong Shenglu Pharmaceutical Betamethasone Product Offerings
Table 104. Shandong Shenglu Pharmaceutical Betamethasone Revenue (US$, Mn), (2016-2021)
Table 105. Maanshan Fengyuan Pharmaceutical Corporate Summary
Table 106. Maanshan Fengyuan Pharmaceutical Betamethasone Product Offerings
Table 107. Maanshan Fengyuan Pharmaceutical Betamethasone Revenue (US$, Mn), (2016-2021)
Table 108. Henan Lihua Pharmaceutical Corporate Summary
Table 109. Henan Lihua Pharmaceutical Betamethasone Product Offerings
Table 110. Henan Lihua Pharmaceutical Betamethasone Revenue (US$, Mn), (2016-2021)
Table 111. SINOPHARM Corporate Summary
Table 112. SINOPHARM Betamethasone Product Offerings
Table 113. SINOPHARM Betamethasone Revenue (US$, Mn), (2016-2021)
Table 114. Chengdu Mount Tiantai Pharmaceutical Corporate Summary
Table 115. Chengdu Mount Tiantai Pharmaceutical Betamethasone Product Offerings
Table 116. Chengdu Mount Tiantai Pharmaceutical Betamethasone Revenue (US$, Mn), (2016-2021)
Table 117. Chenxin Pharmaceutical Corporate Summary
Table 118. Chenxin Pharmaceutical Betamethasone Product Offerings
Table 119. Chenxin Pharmaceutical Betamethasone Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Betamethasone Segment by Type
Figure 2. Betamethasone Segment by Application
Figure 3. Global Betamethasone Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Betamethasone Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Betamethasone Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Betamethasone Revenue in 2020
Figure 8. By Type - Global Betamethasone Revenue Market Share, 2016-2027
Figure 9. By Application - Global Betamethasone Revenue Market Share, 2016-2027
Figure 10. By Region - Global Betamethasone Revenue Market Share, 2016-2027
Figure 11. By Country - North America Betamethasone Revenue Market Share, 2016-2027
Figure 12. US Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Betamethasone Revenue Market Share, 2016-2027
Figure 16. Germany Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 17. France Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Betamethasone Revenue Market Share, 2016-2027
Figure 24. China Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 28. India Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Betamethasone Revenue Market Share, 2016-2027
Figure 30. Brazil Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Betamethasone Revenue Market Share, 2016-2027
Figure 33. Turkey Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Betamethasone Revenue, (US$, Mn), 2016-2027
Figure 37. GlaxoSmithKline Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. East West Pharma Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Omega Remedies Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Moraceae Pharmaceuticals Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Emson Medichem Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Watson Pharma(Allergan) Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Taro Pharmaceuticals Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Icn Pharmaceuticals Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. UCB, Inc Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Fougera Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Impax (Amneal Pharmaceuticals) Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. VersaPharm (Akorn) Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Nucare Pharmaceuticals Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. PD-Rx Pharmaceuticals Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. LEO Pharma Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Orbis Biosciences Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Surface Pharmaceuticals Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Maruho Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Dr. Reddy’s Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Iroko Pharma Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. Tianjin Tianyao Pharmaceutical Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 58. Tianjin Jinyao Group Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 59. Suicheng Pharmaceutical Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 60. Shanghai Pharmaceutical Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 61. Shandong Shenglu Pharmaceutical Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 62. Maanshan Fengyuan Pharmaceutical Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 63. Henan Lihua Pharmaceutical Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 64. SINOPHARM Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 65. Chengdu Mount Tiantai Pharmaceutical Betamethasone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications